Delivery Order SPE2DB25D3003-SPE2DB25FPXCG
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,633.77 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The award is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 3, 2025, for PREVNAR 20 Syringe 0.5ML with a ceiling value of $40,502.71. This firm fixed-price delivery order is set to be completed by September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, PA. The award represents a competitive procurement with no set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency on August 13, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract utilizes firm fixed price terms with an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract, valued at $98,026.20 with a firm fixed price structure, is scheduled for completion by August 11, 2025, and will be performed at the company's corporate office location in Conshohocken, PA 19428. This is a competitively awarded,...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency (DLA) for the supply of Prevnar 20 vaccines in 0.5mL syringes. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The award was executed on August 28, 2025, with an ultimate completion date of August 29, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $32,675.40 by the Defense Logistics Agency on August 15, 2025, for the supply of Prevnar 20 vaccine in 0.5 mL syringe format. This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, with no set-aside designation applied. The award represents a competitively-bid delivery order executed under the company's existing contract vehicle with DLA, reflecting the agency's continued reliance on...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $75,077.70 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order, identified as 4569014593, pertains to the supply of PREVNAR 20 syringes (10-count packages). The contract contains no set-aside designation...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,802.62 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract against AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,442.87 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competed award. Performance of this contract will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,401.39 by the Defense Logistics Agency (DLA) on August 8, 2025. The contract, designated as 4569035711, covers the supply of PREVNAR 20 vaccine in 0.5 milliliter syringes, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXCGDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $24,264.83 by the Defense Logistics Agency for the supply of Prevnar 20 Syringe 0.5ML. The contract, awarded on September 8, 2025, features firm fixed pricing with an ultimate completion date of September 9, 2025. This award was competitively awarded with no set-aside designation and serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies to support military and veteran healthcare systems. This particular order for Prevnar 20 vaccine aligns with the Defense Logistics Agency's ongoing requirement to procure pharmaceutical products and medical commodities that support global military healthcare programs and the Defense Health Agency's operational needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 9/8/25 |